4641-37-6 Usage
Derivative of benzoic acid
A compound that is structurally related to benzoic acid, with modifications to its chemical structure, such as the addition of chlorine atoms and a hydroxyl group.
Contains two chlorine atoms
Chlorine atoms are attached to the benzene ring, which can influence the compound's chemical reactivity, stability, and physical properties.
Contains one hydroxyl group
The presence of a hydroxyl group (-OH) imparts additional functional properties to the compound, such as increased solubility in water and the ability to form hydrogen bonds.
Used as an intermediate in synthesis
The compound serves as a starting material or building block in the production of other chemicals, particularly in the pharmaceutical and agrochemical industries.
Antimicrobial and antifungal properties
The compound exhibits the ability to inhibit the growth or kill microorganisms, such as bacteria and fungi, making it useful in various industrial applications, including disinfectants and preservatives.
Potential role in corrosion inhibition
2,6-Dichloro-3-hydroxybenzoic acid has been studied for its ability to prevent or slow down the corrosion of metals, which could have applications in material protection and surface coatings.
Reactive intermediate in organic chemistry reactions
The compound can participate in various chemical reactions, such as substitution, oxidation, and reduction, to form new compounds with different properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 4641-37-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,6,4 and 1 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 4641-37:
(6*4)+(5*6)+(4*4)+(3*1)+(2*3)+(1*7)=86
86 % 10 = 6
So 4641-37-6 is a valid CAS Registry Number.
4641-37-6Relevant academic research and scientific papers
HIV protease inhibitors
-
, (2008/06/13)
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
HIV protease inhibitors
-
, (2008/06/13)
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
Intermediate and process for making
-
, (2008/06/13)
The present invention provides novel HIV protease inhibitors, pharmaceutical formulations containing those compounds and methods of treating and/or preventing HIV infection and/or AIDS.
Substituted phenyl amidinoureas
-
, (2008/06/13)
This invention relates to a method of lowering blood pressure in humans and mammals using 2,6-disubstituted phenyl amidinoureas in which the phenyl ring is additionally substituted by a hydroxy, alkoxy, aralkoxy, alkenyloxy, alkynyloxy, haloacyloxy, or acyloxy group and to novel 2,6-disubstituted phenyl amidinoureas which possess pharmaceutical properties, including blood pressure lowering activity.
